2426-84-8

Basic information

• Product Name: 4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE
• Synonyms: 4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE;4-(benzyloxy)-5-methoxy-2-nitrobenzaldehyde(SALTDATA: FREE)
• CAS NO: 2426-84-8
• Molecular Formula: C₁₅H₁₃NO₅
• Molecular Weight: 287.27
• Mol File: 2426-84-8.mol
• Article Data: 35

Chemical Properties

• Melting Point: 133 °C
• Boiling Point: 488 °C at 760 mmHg
• Flash Point: 218.9 °C
• Appearance: /
• Density: 1.296 g/cm³
• Vapor Pressure: 1.13E-09mmHg at 25°C
• Refractive Index: 1.615
• CAS DataBase Reference: 4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE(2426-84-8)
• EPA Substance Registry System: 4-(BENZYLOXY)-5-METHOXY-2-NITROBENZALDEHYDE(2426-84-8)

Safety Data

• Hazardous Substances Data: 2426-84-8(Hazardous Substances Data)

Usage

General Description

4-(Benzyloxy)-5-methoxy-2-nitrobenzaldehyde is a chemical compound with the molecular formula C15H13NO5. It is a yellow crystalline solid, commonly used as an intermediate in organic synthesis. 4-(Benzyloxy)-5-methoxy-2-nitrobenzaldehyde is utilized in the manufacturing of various pharmaceuticals, dyes, and other organic products. It possesses both benzyl and methoxy groups, as well as a nitro and aldehyde functional groups, which makes it a versatile molecule for various chemical reactions. The presence of the nitro group makes it suitable for use in nitro-aldol condensation reactions, while the benzyl and methoxy groups provide steric hindrance and influence the reactivity of this compound in different chemical processes. Overall, 4-(Benzyloxy)-5-methoxy-2-nitrobenzaldehyde is an important chemical in the realm of organic synthesis with a variety of practical applications.

InChI:InChI=1/C15H13NO5/c1-20-14-7-12(9-17)13(16(18)19)8-15(14)21-10-11-5-3-2-4-6-11/h2-9H,10H2,1H3

Upstream product

• 2426-87-1 3-methoxy-4-(phenylmethoxy)benzaldehyde 
• 100-39-0 benzyl bromide 
• 121-33-5 vanillin 
• 100-44-7 benzyl chloride 
• 20194-18-7 sodium phenyl-methanolate 
• 712-97-0 6-nitro-1,3-benzodioxole-5-carbaldehyde 
• 82583-99-1 4-Benzyloxy-5-hydroxy-2-nitro-benzaldehyde 
• 77-78-1 dimethyl sulfate 
• 2454-72-0 6-nitrovanillin 
• 92964-17-5 (4-benzyloxy-5-methoxy-2-nitro-phenyl)-acetic acid 

Downstream Products

• 2426-59-7 6-benzyloxy-5-methoxy indole 
• 260417-00-3 4-(hydroxymethyl)-2-methoxy-5-nitrophenol 
• 762245-26-1 (S)-2-(4-benzyloxy-5-methoxy-2-nitrobenzoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid methyl ester 
• 762245-27-2 (S)-(4-(benzyloxy)-5-methoxy-2-nitrophenyl)(3-(hydroxymethyl)-3,4- dihydroisoquinolin-2(1H)-yl)methanone 

Relevant articles and documents

Mussel-inspired healing of a strong and stiff polymer

Self-healability will greatly improve the reliability, service life and maintenance of synthetic materials. However, it remains a big challenge to realize the self-healing of a strong and stiff polymer due to its poor molecular mobility. Inspired by the h

Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols

A series of 9-methoxy-6H-[1]benzothiopyrano[4,3-b]quinolin-10-ols with a Mannich side chain were synthesized and evaluated for their anti-Hepatitis B virus (HBV) activity in HepG2.2.15 cells. Some compounds showed significant anti-HBV activity with IC50 values less than 41 μM. Among them, compound 9b was the most effective anti-HBV agent (IC50 = 1.7 μM, SI = 60.3).

G-A CROSSLINKING CYTOTOXIC AGENTS

The invention relates to a compound of formula (I): or salts, solvates, isomers or tautomers thereof, wherein; A is a group selected from: R1 is selected from H and halogen; either R2 is selected from -CH2-halogen, C1

POLYCYCLIC AMIDES AS CYTOTOXIC AGENTS

The invention relates to a compound of formula (I): or pharmaceutically acceptable salts, solvates, tautomers, stereoisomers or mixtures thereof; wherein the fused ring moiety is a non-alkylating moiety; and wherein the compounds are useful as medicaments, in particular for use as a drug in an antibody-drug conjugate and in the treatment of a proliferative disease, a bacterial infection, a malarial infection and inflammation.